Bulk Manufacturer of Controlled Substances Application: Navinta LLC, 70190 [2020-24465]
Download as PDF
<![CDATA[
70190
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: October 29, 2020.
Lisa Barton,
Secretary to the Commission.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
January 4, 2021.
DATES:
[FR Doc. 2020–24390 Filed 11–3–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–741]
Bulk Manufacturer of Controlled
Substances Application: Navinta LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 25, 2020,
Navinta LLC 1499 Lower Ferry Road,
Ewing, New Jersey 08618–1414, applied
to be registered as an bulk manufacturer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Navinta LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
SUMMARY:
Controlled substance
Drug code
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture active pharmaceutical
ingredients (API) quantities of the listed
controlled substances for validation
purposes and the Food and Drug
Administration’s approval. No other
activity for these drug codes is
authorized for this registration.
DEPARTMENT OF JUSTICE
William T. McDermott,
Assistant Administrator.
AGENCY:
Drug Enforcement Administration
[Docket No. DEA–717]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
[FR Doc. 2020–24465 Filed 11–3–20; 8:45 am]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
BILLING CODE 4410–09–P
SUMMARY:
Cerilliant Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 6, 2020,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, applied to be registered as
an bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ...............................................................................................................................
Naphyrone .......................................................................................................................................................................
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
II
II
II
II
II
comments on or objections to the
issuance of the proposed registration on
or before January 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
January 4, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
Controlled substance
2 All contract personnel will sign appropriate
nondisclosure agreements.
8333
9210
9220
9739
9801
Schedule
E:\FR\FM\04NON1.SGM
04NON1
1233
1235
1237
1238
1246
1248
1249
1258
Schedule
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Page 70190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24465]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-741]
Bulk Manufacturer of Controlled Substances Application: Navinta
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Navinta LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before January 4, 2021.
Such persons may also file a written request for a hearing on the
application on or before January 4, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 25, 2020, Navinta LLC 1499 Lower Ferry
Road, Ewing, New Jersey 08618-1414, applied to be registered as an bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Levomethorphan..................... 9210 II
Levorphanol........................ 9220 II
Remifentanil....................... 9739 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture active pharmaceutical
ingredients (API) quantities of the listed controlled substances for
validation purposes and the Food and Drug Administration's approval. No
other activity for these drug codes is authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-24465 Filed 11-3-20; 8:45 am]
BILLING CODE 4410-09-P
